scholarly journals Epicardial and transverse sinus fat pad near left atrium appendage; role of 3D echocardiography

2020 ◽  
Author(s):  
Reza Mohseni‐badalabadi ◽  
Mohammad Sahebjam ◽  
Mehdi Mohseni‐badalabadi ◽  
Kaveh Hosseini
Keyword(s):  
Left Atrium ◽  
Transverse Sinus ◽  
3D Echocardiography ◽  
Fat Pad

scholarly journals Transverse sinus fat pad near left atrium appendage; Role of 3D echocardiography

2020 ◽  
Author(s):  
reza mohseni badalabadi ◽  
Mohammad Sahebjam ◽  
mehdi mohseni ◽  
kaveh hosseini
Keyword(s):  
Left Atrium ◽  
Transverse Sinus ◽  
3D Echocardiography ◽  
Fat Pad

scholarly journals Epicardial and transverse sinus fat pad near left atrium appendage; Role of 3D echocardiography

2020 ◽  
Author(s):  
reza badalabadi ◽  
mohammad sahebjam ◽  
mehdi badalabadi ◽  
kaveh hosseini
Keyword(s):  
Left Atrium ◽  
Transverse Sinus ◽  
3D Echocardiography ◽  
Fat Pad

The Role of the Buccal Fat Pad in Facial Aesthetic Surgery

2021 ◽  
Vol 148 (2) ◽  
pp. 334-338
Author(s):  
Rod J. Rohrich ◽  
James M. Stuzin ◽  
Ira L. Savetsky ◽  
Yash J. Avashia ◽  
Nikhil A. Agrawal ◽  
...  
Keyword(s):  
Aesthetic Surgery ◽  
Fat Pad ◽  
Buccal Fat Pad

Abstract 1122‐000122: The Role of the Venous System in Infarct Burden in Patients with Acute Ischemic Stroke

2021 ◽  
Vol 1 (S1) ◽  
Author(s):  
Shail S Thanki ◽  
Elliot Pressman ◽  
Shail S Thanki ◽  
John D Mayfield ◽  
Maximilian J Rabil ◽  
...  
Keyword(s):  
Ischemic Stroke ◽  
Acute Ischemic Stroke ◽  
False Negative ◽  
Transverse Sinus ◽  
Sigmoid Sinus ◽  
Venous Sinus ◽  
Post Stroke ◽  
Number Of Patients ◽  
Ct Head

Introduction : Acute ischemic stroke (AIS) is a leading cause of disability internationally. Most therapies focus on intra‐arterial treatment to improve post‐stroke deficits and neurologic status. However, if a relationship between venous anatomy and post‐stroke deficits or infarct size can be shown, then venous augmentation strategies represent a possibility for future interventions as an adjunct to intra‐arterial treatment. Methods : We retrospectively reviewed all ischemic infarcts at our institution that underwent thrombectomy from January 2018 – October 2020. From these, we selected cases that were demonstrated as M1 occlusions on intra‐procedural angiogram and those who had a CT Head obtained within six hours of the patient’s last known normal (LKN). Patients without a CT Head or CT Angiogram of their head were excluded. Using axial and sagittal reconstructed views of 0.9mm slices, cross‐sectional area measurements were taken of the superior sagittal sinus 1cm above the Torcula, in three locations of the ipsilateral and contralateral transverse sinus, in three locations of the ipsilateral and contralateral sigmoid sinus, and of the ipsilateral and contralateral internal jugular vein (IJV) at the external surface of the skull. For the transverse and sigmoid sinuses, the three measurements were averaged together. These measurements were then compared against patient’s Alberta Stroke Program Early CT Score (ASPECTS). Results : 77 patients were identified in the study period. Average ASPECTS was 8.9, ranging from 5–10. There were three patients included with ASPECTS < 6. Average ipsilateral transverse sinus area was 34.4mm ± 3.34, average ipsilateral sigmoid sinus area was 32.8mm ± 2.74, average ipsilateral IJV area was 46.9 mm ± 5.00. Correlation tests to identify relationships between venous sinus area and ASPECTS was unremarkable (ipsilateral transverse sinus p = 0.574, ipsilateral sigmoid sinus p = 0.548, ipsilateral IJV p = 0.798). When assessed as a ratio of ipsilateral venous sinus area to contralateral sinus area to assess correlation with ASPECTS, results were unremarkable (transverse sinus p = 0.891, sigmoid sinus p = 0.292, IJV p = 0.499). Conclusions : Venous sinus size was not found to be predictive or associated with predominantly favorable ASPECTS for strokes found within six hours. We believe this may be due to our cohort lacking significant numbers of patients with low ASPECTS, yielding a false negative result. We are currently expanding this project to include a comparable number of patients with ASPECTS < 6 to determine the role of venous collateral system in infarct progression.

259. Reproductive phenotype of the female aromatase overexpressing mouse

2005 ◽  
Vol 17 (9) ◽  
pp. 105
Author(s):  
J. Liew ◽  
A. E. Drummond ◽  
M. E. Jones ◽  
M. Poutanen ◽  
J. K. Findlay
Keyword(s):  
Gene Expression ◽  
Ovarian Function ◽  
Rna Isolation ◽  
Fat Pad ◽  
Vaginal Smears ◽  
Expression Studies ◽  
Abnormal Pattern ◽  
Gene Expression Studies ◽  
Reproductive Phenotype

Aromatase, the product of the Cyp 19 gene, converts androgens to estrogens. The role of estrogens within the ovary has recently been revisited; using the aromatase knockout (ArKO) mouse, we investigated the effect of estrogen deficiency on ovarian function. We now have an aromatase overexpressing (AROM+) female mouse model with elevated levels of estrogens. These mice were fertile and bred with FVB/N wildtype (WT) males, the AROM+ male being infertile. In this study we characterised the reproductive phenotype of the female AROM+ mouse. 5 WT and 10 AROM+ mice, 22–27 weeks of age were used in the study. The mice were subject to vaginal smears and killed during estrus. The ovaries, uterine horns and gonadal fat were collected and weighed. One ovary and the uterine horns were fixed in formalin for histological assessment, while the other ovary was snap frozen in Ultraspec solution for RNA isolation and gene expression studies. Serum was collected for hormone measurements. All AROM+ mice exhibited an abnormal pattern of cycling that in general, alternated between estrus and post-estrus. AROM+ mice were significantly heavier than their WT counterparts (WT 35.28 ± 2.89 g v. AROM+ 43.38 ± 2.11 g, P < 0.05). Ovarian, uterine and gonadal fat pad weights were not significantly different between the 2 groups (ovary: WT 17.4 ± 1.14 mg v. AROM+ 17.9 ± 0.06 mg; uterine horns: WT 89.7 ± 11.40 mg v. AROM+ 92.1 ± 6.64 mg; gonadal fat pads: WT 2.47 ± 0.62 g v. AROM+ 3.46±0.26 g). Histological, gene expression and hormone analyses are in progress. Our preliminary analyses indicated no significant effect of excess estrogen on ovarian, uterine and gonadal fat pad weights, despite the AROM+ mice being heavier. It remains to be determined as to whether the ovaries and uterine horns are histologically normal. Supported by the NHMRC (Regkeys 241000, 338510, 198705)

Intracoronary adenosine enhances myocardial reactive hyperemia after brief coronary occlusion

1985 ◽  
Vol 248 (6) ◽  
pp. H812-H817
Author(s):  
D. Saito ◽  
T. Hyodo ◽  
K. Takeda ◽  
Y. Abe ◽  
H. Tani ◽  
...  
Keyword(s):  
Blood Flow ◽  
Left Atrium ◽  
Coronary Occlusion ◽  
Reactive Hyperemia ◽  
Control Level ◽  
Direct Effects ◽  
Intracoronary Infusion ◽  
Hyperemic Flow ◽  
Hyperemic Response

Adenosine is a prime candidate for the role of mediator between myocardial metabolic state and coronary blood flow. However, there are few reports concerning the direct effects of exogenously added adenosine on coronary autoregulation. The present investigation in the open-chest dog studied the effects of a threshold dose of intracoronary adenosine infusion on reactive hyperemia following brief coronary occlusions. The infused dose did not increase nonocclusive flow by greater than 10%. Adenosine enhanced total hyperemic flow at all occlusions tested (5, 10, 15, 20, and 30 s). Aminophylline pretreatment reduced reactive hyperemia below the control level even in the presence of an intracoronary infusion of adenosine. Adenosine injected into the left atrium and intracoronarily infused papaverine did not affect hyperemic response to 5- and 15-s coronary occlusions. The results suggest that a minimum dose of exogenously added adenosine enhances myocardial reactive hyperemia, possibly by potentiating the effects of endogenous adenosine released during ischemia.

Sign in / Sign up

Export Citation Format

Share Document